BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5762370)

  • 1. Evaluation of a new concentrate for the treatment of factor IX deficiency.
    Gilchrist GS; Ekert H; Shanbrom E; Hammond D
    N Engl J Med; 1969 Feb; 280(6):291-5. PubMed ID: 5762370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hemophilia].
    Straub PW
    Dtsch Med Wochenschr; 1969 Sep; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of severe haemophilia B with a factor IX concentrate (author's transl)].
    Ludwig E; Lechner K
    Dtsch Med Wochenschr; 1974 Jun; 99(25):1355-61. PubMed ID: 4836072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive treatment of B type hemophilia: comparative evaluation between plasma and a concentrate of factor IX].
    Tribalto M; De Rossi G; Criscuolo D; Roseo I; Guarino S
    Clin Ter; 1975 Aug; 74(3):259-63. PubMed ID: 1227746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)].
    Girolami A; Cella G; Patrassi G
    Haematologica; 1974 Mar; 59(1):91-108. PubMed ID: 4212668
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgical operation in hemophilia B. Use of factor IX concentrate.
    Kasper CK
    Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a cooperative programme of profilactic treatment for haemophilia A and B (author's transl)].
    Sangre (Barc); 1978; 23(5B):780-92. PubMed ID: 725718
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary infarct in a child with hemophilia B (Christmas disease) after transfusion of large amounts of antihemophilic plasma].
    Mastalska A; Judkiewicz L; Janiszewska-Fronczak M; Gołebiowska M
    Wiad Lek; 1980 May; 33(9):735-8. PubMed ID: 7405242
    [No Abstract]   [Full Text] [Related]  

  • 10. Serologic evidence of hepatitis B virus infection in patients with hemophilia B. a multicenter study.
    Hoofnagle JH; Aronnon D; Roberts H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):606-9. PubMed ID: 1154315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
    Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
    Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated intravascular coagulation after factor IX complex resolved using purified factor IX concentrate.
    Hadley T; Djulbegovic B
    Ann Intern Med; 1991 Oct; 115(8):621-2. PubMed ID: 1892334
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum transfusion in hemophiliacs.
    Kimura A
    Tohoku J Exp Med; 1973 Oct; 111(2):125-36. PubMed ID: 4784393
    [No Abstract]   [Full Text] [Related]  

  • 15. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of self-treatment in hemophilias. Preliminary report].
    Göbel U; Schulz RD
    Dtsch Med Wochenschr; 1972 Sep; 97(37):1376-9. PubMed ID: 5055724
    [No Abstract]   [Full Text] [Related]  

  • 20. A new drug form of blood coagulation factor IX: red blood cell-entrapped factor IX.
    Sinauridze EI; Vuimo TA; Kulikova EV; Shmyrev II; Ataullakhanov FI
    Med Sci Monit; 2010 Oct; 16(10):PI19-26. PubMed ID: 20885362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.